Luye Pharma Group had a revenue of 3.07B in the quarter ending Jun 30, 2024, with -5.08%. This bring the company's revenue in the last twelve months to 7.93B, Decreased 2.20%. In the fiscal year ending Dec 31, 2023, Luye Pharma Group had annual revenue of 6.14B with 2.70% growth.